Soft tissue Langerhans cell histiocytosis with secondary bone involvement in extremities: evolution of lesions in two patients

被引:7
作者
Amini, Behrang [1 ]
Kumar, Rajendra [1 ]
Wang, Wei-Lien [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Div Diagnost Imaging, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
Langerhans cell histiocytosis; Soft tissue lesions; Positron-emission tomography; Natural history; Chemotherapy; FOLLOW-UP; FDG-PET; CONVENTIONAL RADIOGRAPHY; EOSINOPHILIC GRANULOMA; MANAGEMENT; DIAGNOSIS; SCINTIGRAPHY; CLADRIBINE; REGISTRY; SOCIETY;
D O I
10.1007/s00256-013-1611-x
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Langerhans cell histiocytosis (LCH) is an uncommon disorder of unknown etiology with a wide spectrum of biological behavior. The most common sites of involvement are bone, skin, and lung. While osseous LCH can result in secondary soft tissue involvement, primary soft tissue LCH in extremities with secondary bone involvement is rare, and little is known about its natural course. We report two adult patients with multi-organ system LCH who had primary soft tissue lesions with secondary involvement of adjoining bones in lower extremities, and illustrate the important role played by various imaging modalities in detection and monitoring of treatment response. We also document spontaneous clinical resolution of LCH lesions without therapy, and positive response of these lesions to chemotherapy.
引用
收藏
页码:1301 / 1309
页数:9
相关论文
共 36 条
[1]   Langerhans cell histiocytosis: Current concepts and treatments [J].
Abla, Oussama ;
Egeler, R. Maarten ;
Weitzman, Sheila .
CANCER TREATMENT REVIEWS, 2010, 36 (04) :354-359
[2]  
AlAbbadi M, 1997, ARCH PATHOL LAB MED, V121, P169
[3]   Langerhans cell histiocytosis in adults:: more questions than answers? [J].
Aricò, M .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (10) :1467-1473
[4]   Langerhans cell histiocytosis in adults report from the International Registry of the Histiocyte Society [J].
Aricò, M ;
Girschikofsky, M ;
Généreau, T ;
Klersy, C ;
McClain, K ;
Grois, N ;
Emile, JF ;
Lukina, E ;
De Juli, E ;
Danesino, C .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (16) :2341-2348
[5]   Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findings [J].
Binkovitz, LA ;
Olshefski, RS ;
Adler, BH .
PEDIATRIC RADIOLOGY, 2003, 33 (09) :598-602
[6]  
BROADBENT V, 1984, LANCET, V1, P253
[7]   Langerhans cell histiocytosis with central nervous system involvement:: Follow-up by FDG-PET during treatment with cladribine [J].
Büchler, T ;
Cervinek, L ;
Belohlavek, O ;
Kantorova, I ;
Mechl, M ;
Nebesky, T ;
Vorlicek, J ;
Adam, Z .
PEDIATRIC BLOOD & CANCER, 2005, 44 (03) :286-288
[8]   Detection of bone lesions in Langerhans cell histiocytosis: Complementary roles of scintigraphy and conventional radiography [J].
Dogan, AS ;
Conway, JJ ;
Miller, JH ;
Grier, D ;
Bhattathiry, MM ;
Mitchell, CS .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1996, 18 (01) :51-58
[9]  
Donadieu J, 1996, ARCH DIS CHILD, V75, P17
[10]   Medical management of langerhans cell histiocytosis from diagnosis to treatment [J].
Donadieu, Jean ;
Chalard, Francois ;
Jeziorski, Eric .
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (09) :1309-1322